SMARCA2 and lung cancer: Analysis of a total of 316 lung cancers found complete loss of BRG1 in 5.5% of lung adenocarcinomas and 5.2% of squamous cells, and complete loss of BRM in 6.4% of adenocarcinomas and only 1.7% of squamous cells (Herpel et al., 2017).